2,463
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers

, , , , &
Pages 1003-1009 | Accepted 27 Aug 2013, Published online: 04 Oct 2013

References

  • Ainbinder D, Paolino D, Fresta M, et al. (2010). Drug delivery applications with ethosomes. J Biomed Nanotechnol 6:558–68
  • Alves MP, Scarrone AL, Santos M, et al. (2007). Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 341:215–20
  • Azeem A, Anwer MK, Talegaonkar S. (2009). Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 17:671–89
  • Barichello JM, Handa H, Kisyuku M, et al. (2006). Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state. J Control Release 115:94–102
  • Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–14
  • Castro GA, Ferreira LA. (2008). Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv 5:665–79
  • Da SD, Thiago SB, Pessoa FA, et al. (2008). Penetration profile of taurine in the human skin and its distribution in skin layers. Pharm Res 25:1846–50
  • Dhote V, Bhatnagar P, Mishra PK, et al. (2012). Iontophoresis: a potential emergence of a transdermal drug delivery system. Sci Pharm 80:1–28
  • di Cagno M, Luppi B. (2013). Drug “supersaturation” states induced by polymeric micelles and liposomes: a mechanistic investigation into permeability enhancements. Eur J Pharm Sci 48:775–80
  • Elsayed MM, Abdallah OY, Naggar VF, et al. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322:60–6
  • Elsayed MM, Abdallah OY, Naggar VF, et al. (2007). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1–16
  • Finn DA, Beadles-Bohling AS, Beckley EH, et al. (2006). A new look at the 5alpha-reductase inhibitor finasteride. Cns Drug Rev 12:53–76
  • Gillet A, Compere P, Lecomte F, et al. (2011). Liposome surface charge influence on skin penetration behaviour. Int J Pharm 411:223–31
  • Godin B, Touitou E. (2003). Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20:63–102
  • Gupta M, Agrawal U, Vyas SP. (2012). Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 9:783–804
  • Heard CM, Monk BV, Modley AJ. (2003). Binding of primaquine to epidermal membranes and keratin. Int J Pharm 257:237–44
  • Jun-Bo T, Zhuang-Qun Y, Xi-Jing H, et al. (2007). Effect of ethosomalminoxidil on dermal delivery and hair cycle of C57BL/6 mice. J DermatolSci 45:135–7
  • Kuo TR, Wu CL, Hsu CT, et al. (2009). Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 30:3002–8
  • Li G, Fan Y, Fan C, et al. (2012). Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 82:49–57
  • Libecco JF, Bergfeld WF. (2004). Finasteride in the treatment of alopecia. Expert Opin Pharmacother 5:933–40
  • Liu S, Yamauchi H. (2008). Different patterns of 5alpha-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells. Biochem Biophys Res Commun 368:858–64
  • Pierre MB, Dos SMCI. (2011). Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res 303:607–21
  • Qi LW, Li P, Li SL, et al. (2006). Screening and identification of permeable components in a combined prescription of DangguiBuxue decoction using a liposome equilibrium dialysis system followed by HPLC and LC-MS. J Sep Sci 29:2211–20
  • Rao Y, Zheng F, Zhang X, et al. (2008). In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS Pharm Sci Tech 9:860–5
  • Schroeter A, Engelbrecht T, Neubert RH, et al. (2010). New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol 6:511–28
  • Shi J, Wang Y, Luo G. (2012). Ligustrazine phosphate ethosomes for treatment of Alzheimer's disease, in vitro and in animal model studies. AAPS Pharm Sci Tech 13:485–92
  • Shumilov M, Bercovich R, Duchi S, et al. (2010). Ibuprofen transdermal ethosomal gel: characterization and efficiency in animal models. J Biomed Nanotechnol 6:569–76
  • Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18
  • Touitou E. (1996). Compositions for applying active substances to or through the skin. US patent 5540934
  • Traish AM, Hassani J, Guay AT, et al. (2011). Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med 8:872–84
  • Trueb RM. (2002). Molecular mechanisms of androgenetic alopecia. Exp Gerontol 37:981–90
  • van der Maaden K, Jiskoot W, Bouwstra J. (2012). Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161:645–55
  • Verma P, Pathak K. (2012). Nanosizedethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 8:489–96
  • Xu DH, Zhang Q, Feng X, et al. (2007). Synergistic effects of ethosomes and chemical enhancers on enhancement of naloxone permeation through human skin. Pharmazie 62:316–18
  • Zhou Y, Wei Y, Liu H, et al. (2010). Preparation and in vitro evaluation of ethosomal total alkaloids of Sophoraalopecuroides loaded by a transmembrane pH-gradient method. AAPS Pharm Sci Tech 11:1350–8
  • Zhou Y, Wei YH, Zhang GQ, et al. (2010). Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Arch Pharm Res 33:567–74

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.